These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9386213)

  • 1. HRT and the risk of deep vein thrombosis.
    Barlow DH
    Int J Gynaecol Obstet; 1997 Oct; 59 Suppl 1():S29-33. PubMed ID: 9386213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone replacement therapy and venous thromboembolism.
    Wu O
    Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
    Jick H; Derby LE; Myers MW; Vasilakis C; Newton KM
    Lancet; 1996 Oct; 348(9033):981-3. PubMed ID: 8855853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.
    Castellsague J; Pérez Gutthann S; García Rodríguez LA
    Drug Saf; 1998 Feb; 18(2):117-23. PubMed ID: 9512918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and venous thromboembolism.
    Eisenberger A; Westhoff C
    J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism in users of hormone replacement therapy.
    Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
    Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
    Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thrombo-embolism and hormone replacement therapy.
    Whitehead M; Godfree V
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):587-99. PubMed ID: 9488793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of exogenous hormones and risk of pulmonary embolism in women.
    Grodstein F; Stampfer MJ; Goldhaber SZ; Manson JE; Colditz GA; Speizer FE; Willett WC; Hennekens CH
    Lancet; 1996 Oct; 348(9033):983-7. PubMed ID: 8855854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism.
    Grady D; Sawaya G
    Am J Med; 1998 Jul; 105(1):41-3. PubMed ID: 9688020
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
    Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
    Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent concerns surrounding HRT.
    Armitage M; Nooney J; Evans S
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD; Lawrenson RA
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
    Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
    Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study.
    Renoux C; Dell'Aniello S; Suissa S
    J Thromb Haemost; 2010 May; 8(5):979-86. PubMed ID: 20230416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1995 Dec; 346(8990):1575-82. PubMed ID: 7500748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of pulmonary embolism.
    Goldhaber SZ
    Semin Vasc Med; 2001 Nov; 1(2):139-46. PubMed ID: 15199496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.